Acute Respiratory Infections (ARIs) are responsible for 4.25 million deaths annually and are the third largest cause of mortality in the world.1
The clinical manifestations of viral and bacterial illnesses are often similar and may require testing to differentiate between them.
Rapid assays at the point of care have been helpful in particular situations but still offer very limited data because they only test for one pathogen. Results from a rapid, in-office test can lead to a false sense of security for both the patient and the clinician, resulting in the delay of an accurate diagnosis and the progression of the disease due to other vital pathogens being omitted.
Comprehensive molecular diagnostics are needed to help clinicians accurately diagnose and appropriately treat their patients within an acceptable time frame.
1 Ferkol, Thomas & Schraufnagel, Dean (2013). The Global Burden of Respiratory Disease. ATS Journals, Vol. 11, No.3.